COMPARISON OF OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION WITH OR WITHOUT PRIOR CHEMOTHERAPY FOR MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引:0
|
作者
Mo, X. -D. [1 ]
Zhang, X. -H. [1 ]
Xu, L. -P. [1 ]
Wang, Y. [1 ]
Yan, C. -H. [1 ]
Chen, H. [1 ]
Chen, Y. -H. [1 ]
Han, W. [1 ]
Wang, F. -R. [1 ]
Wang, J. -Z. [1 ]
Liu, K. -Y. [1 ]
Huang, X. -J. [1 ]
机构
[1] Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E1515
引用
收藏
页码:618 / 618
页数:1
相关论文
共 50 条
  • [31] Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation
    Aladag, Elifcan
    Goker, Hakan
    Buyukasik, Yahya
    Demiroglu, Haluk
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (01) : 391 - 395
  • [32] Efficacy of donor lymphocyte infusion following cytoreductive chemotherapy for relapsed acute leukaemia after allogeneic stem cell transplantation
    Kim, DY
    Lee, KW
    Yun, T
    Kim, SI
    Park, SR
    Paik, JY
    Choi, IS
    Oh, DY
    Yoon, SS
    Lee, JS
    Park, S
    Kim, BK
    BONE MARROW TRANSPLANTATION, 2004, 33 : S99 - S99
  • [33] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE WITH OR WITHOUT PROPHYLACTIC DONOR LYMPHOCYTE INFUSION AFTER HLA-MATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MDS/AML
    van der Hem, Joost
    Versluis, Jurjen
    Erpelinck, Iris
    Mouws, Chantal
    Von dem Borne, Peter
    Broers, Annoek
    Halkes, Stijn
    BONE MARROW TRANSPLANTATION, 2024, 59 : 303 - 303
  • [34] Comparison of Prophylactic and Preemptive Donor Lymphocyte Infusion in Patients with Very High Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Yang, Luxin
    Luo, Yi
    Huang, He
    Tan, Yamin
    Shi, Jimin
    Zhao, Yanmin
    Yu, Jian
    Lai, Xiaoyu
    BLOOD, 2021, 138 : 3860 - +
  • [35] Prognostic significance of minimal residual disease after hematopoietic stem cell transplantation
    Gruhn, B
    Häfer, R
    Voigt, A
    Wittig, S
    Fuchs, D
    Hermann, J
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2002, 29 : S124 - S124
  • [36] Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation
    Ho, Vincent T.
    Kim, Haesook T.
    Kao, Grace
    Cutler, Corey
    Levine, James
    Rosenblatt, Jacalyn
    Joyce, Robin
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    Avigan, David
    Alyea, Edwin P., III
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) : 1092 - 1096
  • [37] Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant
    Lemieux, Christopher
    Muffly, Lori S.
    Arai, Sally
    Rezvani, Andrew R.
    Sidana, Surbhi
    Johnston, Laura J.
    Weng, Wen-Kai
    Shiraz, Parveen
    Frank, Matthew J.
    Meyer, Everett H.
    Shizuru, Judith A.
    Miklos, David B.
    Negrin, Robert S.
    Lowsky, Robert
    BLOOD, 2020, 136
  • [38] Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Solarska, Iwona
    Nasilowska-Adamska, Barbara
    Bieniaszewska, Maria
    Zaucha, Jan Maciej
    Rzepecki, Piotr
    Sawicki, Waldemar
    Calbecka, Malgorzata
    Lech-Maranda, Ewa
    Marianska, Bozena
    Warzocha, Krzysztof
    BLOOD, 2009, 114 (22) : 1266 - 1266
  • [39] Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Dominietto, Alida
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 381 - 387
  • [40] Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
    Xiao-Dong Mo
    Ya-Zhen Qin
    Xiao-Hui Zhang
    Lan-Ping Xu
    Yu Wang
    Chen-Hua Yan
    Huan Chen
    Yu-Hong Chen
    Wei Han
    Feng-Rong Wang
    Jing-Zhi Wang
    Kai-Yan Liu
    Xiao-Jun Huang
    Annals of Hematology, 2016, 95 : 1233 - 1240